Goldman Sachs’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.77M Buy
43,188
+5,531
+15% +$355K ﹤0.01% 3209
2025
Q1
$2.39M Buy
37,657
+2,103
+6% +$133K ﹤0.01% 3244
2024
Q4
$2.37M Buy
35,554
+29,709
+508% +$1.98M ﹤0.01% 3368
2024
Q3
$408K Buy
+5,845
New +$408K ﹤0.01% 4217
2023
Q3
Sell
-5,454
Closed -$334K 4883
2023
Q2
$334K Sell
5,454
-2,067
-27% -$127K ﹤0.01% 4183
2023
Q1
$472K Buy
7,521
+99
+1% +$6.21K ﹤0.01% 4096
2022
Q4
$471K Buy
+7,422
New +$471K ﹤0.01% 4120
2022
Q1
Sell
-6,361
Closed -$453K 5856
2021
Q4
$453K Sell
6,361
-7,063
-53% -$503K ﹤0.01% 4580
2021
Q3
$1.01M Buy
+13,424
New +$1.01M ﹤0.01% 3964
2017
Q4
Sell
-5,120
Closed -$256K 4258
2017
Q3
$256K Sell
5,120
-1,384
-21% -$69.2K ﹤0.01% 3784
2017
Q2
$297K Sell
6,504
-5,832
-47% -$266K ﹤0.01% 3802
2017
Q1
$522K Sell
12,336
-53,905
-81% -$2.28M ﹤0.01% 3495
2016
Q4
$2.57M Buy
66,241
+5
+0% +$194 ﹤0.01% 2556
2016
Q3
$2.78M Sell
66,236
-582
-0.9% -$24.4K ﹤0.01% 2535
2016
Q2
$2.47M Buy
66,818
+47
+0.1% +$1.74K ﹤0.01% 2500
2016
Q1
$2.56M Buy
66,771
+479
+0.7% +$18.3K ﹤0.01% 2395
2015
Q4
$3.35M Sell
66,292
-367
-0.6% -$18.5K ﹤0.01% 2258
2015
Q3
$3.05M Sell
66,659
-1,334
-2% -$61K ﹤0.01% 2299
2015
Q2
$3.97M Sell
67,993
-1,569
-2% -$91.5K ﹤0.01% 2201
2015
Q1
$3.84M Buy
69,562
+5,326
+8% +$294K ﹤0.01% 2170
2014
Q4
$3.23M Sell
64,236
-1,216
-2% -$61.1K ﹤0.01% 2232
2014
Q3
$3.03M Sell
65,452
-26,160
-29% -$1.21M ﹤0.01% 2274
2014
Q2
$4M Buy
91,612
+70,903
+342% +$3.1M ﹤0.01% 2135
2014
Q1
$862K Buy
20,709
+10,411
+101% +$433K ﹤0.01% 3084
2013
Q4
$382K Buy
+10,298
New +$382K ﹤0.01% 3578